Radioembolization with Yttrium-90 glass microspheres is a safe and effective treatment for patients with advanced HCC portal vein thrombosis, according to new research. Radioembolisation with ...
Singapore, 10 October 2024 – A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of ...
BRUSSELS, August 19, 2010 /PRNewswire/ -- Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care ...
Please note - this trial is no longer recruiting patients. We hope to add results when they are available. This study is to see if adding radioembolisation to chemotherapy improves treatment for ...
This multi-centre phase II clinical trial is the first prospective evaluation of radioembolisation of patients with colorectal liver metastases (mCRC) who failed previous oxaliplatin- and ...
Please note - this trial is no longer recruiting patients. We hope to add results when they are available. The researchers think that having radioembolisation before starting sorafenib may be better ...
BTG plc, an international specialist healthcare company, announced that the first patient in Malaysia was treated with TheraSphere - a transarterial radioembolisation (TARE) therapy, which targets ...
Copenhagen, Denmark, Friday 24 April: Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC ± portal vein thrombosis, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results